FGF12 antibody (AA 1-181)

Catalog No. ABIN560869

This Mouse Monoclonal antibody specifically detects FGF12 in WB, ELISA and IHC (p). It exhibits reactivity toward Humanand has been mentioned in 1 publication.

Quick Overview for FGF12 antibody (AA 1-181) (ABIN560869)

Target: FGF12 (Fibroblast Growth Factor 12 (FGF12))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FGF12 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: 1D9

Product Details anti-FGF12 Antibody

Binding Specificity: AA 1-181

Purpose: Mouse monoclonal antibody raised against a full length recombinant FGF12.

Sequence: MESKEPQLKG IVTRLFSQQG YFLQMHPDGT IDGTKDENSD YTLFNLIPVG LRVVAIQGVK ASLYVAMNGE GYLYSSDVFT PECKFKESVF ENYYVIYSST LYRQQESGRA WFLGLNKEGQ IMKGNRVKKT KPSSHFVPKP IEVCMYREQS LHEIGEKQGR SRKSSGTPTM NGGKVVNQDS T

Cross-Reactivity: Human

Characteristics: Antibody Reactive Against Recombinant Protein.

Immunogen: FGF12 (AAH22524, 1 a.a. ~ 181 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: In 1x PBS, pH 7.4

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

References for anti-FGF12 antibody (ABIN560869)

Chattopadhyay, Singh, Phukan, Purkayastha, Kataki, Mahanta, Saxena, Kapur: "Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India." in: Mutation research, Vol. 696, Issue 2, pp. 130-8, (2010) (PubMed).

Target Details for FGF12

Target: FGF12 (Fibroblast Growth Factor 12 (FGF12))

Alternative Name: FGF12

Background: Full Gene Name: fibroblast growth factor 12
Synonyms: FGF12B,FHF1

Gene ID: 2257

Pathways: Negative Regulation of Transporter Activity